Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sjögren's syndrome

Journal of Immunology

Volumn 188, Issue 9, 2012, Pages 4654-4662

  Inoue, Hiroko ^a   Mishima, Kenji ^a,b   Yamamoto Yoshida, Sachi ^a   Ushikoshi Nakayama, Ryoko ^a   Nakagawa, Yoichi ^a   Yamamoto, Ken ^a   Ryo, Kofuchi ^a   Ide, Fumio ^a   Saito, Ichiro ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; GENOMIC DNA; IMMEDIATE EARLY PROTEIN BZLF1; MESSENGER RNA; VIRUS DNA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENETIC RISK; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SALIVA ANALYSIS; SALIVARY GLAND; SJOEGREN SYNDROME; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS INDUCTION; VIRUS REACTIVATION; XEROSTOMIA;

ANIMALS; B-LYMPHOCYTES; CALLITHRIX; CELL LINE, TRANSFORMED; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL POLLUTANTS; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; RECEPTORS, ARYL HYDROCARBON; RISK FACTORS; SALIVARY GLANDS; SJOGREN'S SYNDROME; TETRACHLORODIBENZODIOXIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VIRUS ACTIVATION;

EID: 84860340499     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101575     Document Type: Article

References (76)

1. Schmidt, J. V., and C. A. Bradfield. 1996. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12: 55-89. (Pubitemid 26422709)
2. Rowlands, J. C., and J. A. Gustafsson. 1997. Aryl hydrocarbon receptor-mediated signal transduction. Crit. Rev. Toxicol. 27: 109-134. (Pubitemid 27158455)
3. Couture, L. A., B. D. Abbott, and L. S. Birnbaum. 1990. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo- p-dioxin: recent advances toward understanding the mechanism. Teratology 42: 619-627.
4. Burleson, G. R., H. Lebrec, Y. G. Yang, J. D. Ibanes, K. N. Pennington, and L. S. Birnbaum. 1996. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam. Appl. Toxicol. 29: 40-47.
5. Murayama, T., M. Inoue, T. Nomura, S. Mori, and Y. Eizuru. 2002. 2,3,7,8-Tetrachlorodibenzo-p-dioxin is a possible activator of human cytomegalovirus replication in a human fibroblast cell line. Biochem. Biophys. Res. Commun. 296: 651-656.
6. Ohata, H., T. Tetsuka, H. Hayashi, K. Onozaki, and T. Okamoto. 2003. 3-Methylcholanthrene activates human immunodeficiency virus type 1 replication via aryl hydrocarbon receptor. Microbiol. Immunol. 47: 363-370. (Pubitemid 36604622)
7. Garssen, J., H. Van der Vliet, A. De Klerk, W. Goettsch, J. A. Dormans, C. A. Bruggeman, A. D. Osterhaus, and H. Van Loveren. 1995. A rat cytomegalovirus infection model as a tool for immunotoxicity testing. Eur. J. Pharmacol. 292: 223-231.
8. Babcock, G. J., L. L. Decker, M. Volk, and D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9: 395-404. (Pubitemid 28462760)
9. Münz, C., J. D. Lünemann, M. T. Getts, and S. D. Miller. 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9: 246-258.
10. Countryman, J., and G. Miller. 1985. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA 82: 4085-4089. (Pubitemid 15052833)
11. Rooney, C. M., D. T. Rowe, T. Ragot, and P. J. Farrell. 1989. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J. Virol. 63: 3109-3116. (Pubitemid 19156033)
12. Speck, S. H., T. Chatila, and E. Flemington. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5: 399-405. (Pubitemid 27417826)
13. Flemington, E., and S. H. Speck. 1990. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64: 1217-1226. (Pubitemid 20087760)
14. Montalvo, E. A., M. Cottam, S. Hill, and Y. J. Wang. 1995. YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J. Virol. 69: 4158-4165.
15. zur Hausen, H., F. J. O'Neill, U. K. Freese, and E. Hecker. 1978. Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272: 373-375. (Pubitemid 8308093)
16. Takada, K. 1984. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33: 27-32. (Pubitemid 14223229)
17. Luka, J., B. Kallin, and G. Klein. 1979. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94: 228-231. (Pubitemid 9164800)
18. Sulentic, C. E., M. P. Holsapple, and N. E. Kaminski. 1998. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p- dioxin of IgM secretion in activated B cells. Mol. Pharmacol. 53: 623-629. (Pubitemid 28196483)
19. Crawford, D. H., and I. Ando. 1986. EB virus induction is associated with B-cell maturation. Immunology 59: 405-409. (Pubitemid 16007091)
20. Fox, R. I., T. Bumol, R. Fantozzi, R. Bone, and R. Schreiber. 1986. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum. 29: 1105-1111. (Pubitemid 16017801)
21. Fox, R. I., G. Pearson, and J. H. Vaughan. 1986. Detection of Epstein-Barr virusassociated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J. Immunol. 137: 3162-3168. (Pubitemid 17181684)
22. Saito, I., B. Servenius, T. Compton, and R. I. Fox. 1989. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J. Exp. Med. 169: 2191-2198. (Pubitemid 19162976)
23. Tateishi, M., I. Saito, K. Yamamoto, and N. Miyasaka. 1993. Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome: possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. Arthritis Rheum. 36: 827-835. (Pubitemid 23175626)
24. Mariette, X., J. Gozlan, D. Clerc, M. Bisson, and F. Morinet. 1991. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am. J. Med. 90: 286-294.
25. Yanagawa, T., Y. Hayashi, S. Nagamine, H. Yoshida, Y. Yura, and M. Sato. 1986. Generation of cells with phenotypes of both intercalated duct-type and myoepithelial cells in human parotid gland adenocarcinoma clonal cells grown in athymic nude mice. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 51: 187-195. (Pubitemid 16084105)
26. Karras, J. G., and M. P. Holsapple. 1994. Mechanisms of 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD)-induced disruption of B-lymphocyte signaling in the mouse: a current perspective. Exp. Clin. Immunogenet. 11: 110-118. (Pubitemid 24305631)
27. Allan, L. L., and D. H. Sherr. 2005. Constitutive activation and environmental chemical induction of the aryl hydrocarbon receptor/transcription factor in activated human B lymphocytes. Mol. Pharmacol. 67: 1740-1750. (Pubitemid 40594175)
28. Crawford, R. B., M. P. Holsapple, and N. E. Kaminski. 1997. Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand. Mol. Pharmacol. 52: 921-927. (Pubitemid 28013709)
29. Morris, D. L., J. G. Karras, and M. P. Holsapple. 1993. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells. Immunopharmacology 26: 105-112. (Pubitemid 23280756)
30. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79: 1296-1307. (Pubitemid 40053911)
31. Hadinoto, V., M. Shapiro, C. C. Sun, and D. A. Thorley-Lawson. 2009. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog. 5: e1000496.
32. Sixbey, J. W., J. G. Nedrud, N. Raab-Traub, R. A. Hanes, and J. S. Pagano. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310: 1225-1230. (Pubitemid 14140362)
33. Wolf, H., M. Haus, and E. Wilmes. 1984. Persistence of Epstein-Barr virus in the parotid gland. J. Virol. 51: 795-798. (Pubitemid 14063158)
34. Hoover, S. E., J. Kawada, W. Wilson, and J. I. Cohen. 2008. Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells. J. Infect. Dis. 198: 318-323.
35. Ruf, I. K., and D. R. Rawlins. 1995. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter. J. Virol. 69: 7648-7657.
36. Saito, I., S. Nishimura, I. Kudo, R. I. Fox, and I. Moro. 1991. Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoproliferative diseases by the polymerase chain reaction. Arch. Oral Biol. 36: 779-784.
37. Fox, R. I., M. Stern, and P. Michelson. 2000. Update in Sjögren syndrome. Curr. Opin. Rheumatol. 12: 391-398.
38. Fox, R. I. 2005. Sjögren's syndrome. Lancet 366: 321-331.
39. Salomonsson, S., M. V. Jonsson, K. Skarstein, K. A. Brokstad, P. Hjelmström, M. Wahren-Herlenius, and R. Jonsson. 2003. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum. 48: 3187-3201. (Pubitemid 37409331)
40. Routsias, J. G., and A. G. Tzioufas. 2007. Sjögren's syndrome: study of autoantigens and autoantibodies. Clin. Rev. Allergy Immunol. 32: 238-251. (Pubitemid 350242570)
41. Bertazzi, P. A., I. Bernucci, G. Brambilla, D. Consonni, and A. C. Pesatori. 1998. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ. Health Perspect. 106(Suppl 2): 625-633. (Pubitemid 28256770)
42. Bertazzi, P. A., D. Consonni, S. Bachetti, M. Rubagotti, A. Baccarelli, C. Zocchetti, and A. C. Pesatori. 2001. Health effects of dioxin exposure: a 20-year mortality study. Am. J. Epidemiol. 153: 1031-1044. (Pubitemid 32493249)
43. Okano, M., G. M. Thiele, J. R. Davis, H. L. Grierson, and D. T. Purtilo. 1988. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin. Microbiol. Rev. 1: 300-312.
44. Hardell, L., G. Lindström, B. van Bavel, K. Hardell, A. Linde, M. Carlberg, and G. Liljegren. 2001. Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma. Environ. Res. 87: 99-107. (Pubitemid 32964592)
45. Fox, R. I., I. Saito, E. K. Chan, S. Josephs, S. Z. Salahuddin, D. V. Ahlashi, F. W. Staal, R. Gallo, H. Pei-Ping, and C. S. Le. 1989. Viral genomes in lymphomas of patients with Sjögren's syndrome. J. Autoimmun. 2: 449-455.
46. Fox, R. I., M. Luppi, H. I. Kang, and P. Pisa. 1991. Reactivation of Epstein-Barr virus in Sjögren's syndrome. Springer Semin. Immunopathol. 13: 217-231.
47. Van Wouwe, N., I. Windal, H. Vanderperren, G. Eppe, C. Xhrouet, A. C. Massart, N. Debacker, A. Sasse, W. Baeyens, E. De Pauw, et al. 2004. Validation of the CALUX bioassay for PCDD/F analyses in human blood plasma and comparison with GC-HRMS. Talanta 63: 1157-1167.
48. Laier, P., T. Cederberg, J. C. Larsen, and A. M. Vinggaard. 2003. Applicability of the CALUX bioassay for screening of dioxin levels in human milk samples. Food Addit. Contam. 20: 583-595. (Pubitemid 36833996)
49. Tsutsumi, T., Y. Amakura, M. Nakamura, D. J. Brown, G. C. Clark, K. Sasaki, M. Toyoda, and T. Maitani. 2003. Validation of the CALUX bioassay for the screening of PCDD/Fs and dioxin-like PCBs in retail fish. Analyst (Lond.) 128: 486-492. (Pubitemid 36606188)
50. Joung, K. E., Y. H. Chung, and Y. Y. Sheen. 2007. DRE-CALUX bioassay in comparison with HRGC/MS for measurement of toxic equivalence in environmental samples. Sci. Total Environ. 372: 657-667. (Pubitemid 46043378)
51. Nording, M., M. S. Denison, D. Baston, Y. Persson, E. Spinnel, and P. Haglund. 2007. Analysis of dioxins in contaminated soils with the calux and caflux bioassays, an immunoassay, and gas chromatography/high-resolution mass spectrometry. Environ. Toxicol. Chem. 26: 1122-1129. (Pubitemid 46932670)
52. Sun, C. C., and D. A. Thorley-Lawson. 2007. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J. Virol. 81: 13566-13577. (Pubitemid 350247850)
53. Chen, Y. H., and R. H. Tukey. 1996. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271: 26261-26266. (Pubitemid 26347475)
54. Cooper, A., E. Johannsen, S. Maruo, E. Cahir-McFarland, D. Illanes, D. Davidson, and E. Kieff. 2003. EBNA3A association with RBP-Jκ down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J. Virol. 77: 999-1010. (Pubitemid 36055522)
55. Maruo, S., E. Johannsen, D. Illanes, A. Cooper, and E. Kieff. 2003. Epstein-Barr virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J. Virol. 77: 10437-10447. (Pubitemid 37129688)
56. Kashuba, E. V., K. Gradin, M. Isaguliants, L. Szekely, L. Poellinger, G. Klein, and A. Kazlauskas. 2006. Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J. Biol. Chem. 281: 1215-1223.
57. Kolluri, S. K., C. Weiss, A. Koff, and M. Göttlicher. 1999. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13: 1742-1753. (Pubitemid 29325878)
58. Yamaguchi, K., R. I. Near, R. A. Matulka, A. Shneider, P. Toselli, A. F. Trombino, and D. H. Sherr. 1997. Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. J. Immunol. 158: 2165-2173. (Pubitemid 127469999)
59. Ge, N. L., and C. J. Elferink. 1998. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein: linking dioxin signaling to the cell cycle. J. Biol. Chem. 273: 22708-22713. (Pubitemid 28399842)
60. Tian, Y., S. Ke, M. S. Denison, A. B. Rabson, and M. A. Gallo. 1999. Ah receptor and NF-κB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274: 510-515. (Pubitemid 29035090)
61. Joseph, A. M., G. J. Babcock, and D. A. Thorley-Lawson. 2000. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J. Virol. 74: 9964-9971.
62. Babcock, G. J., D. Hochberg, and A. D. Thorley-Lawson. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13: 497-506.
63. Nagata, Y., H. Inoue, K. Yamada, H. Higashiyama, K. Mishima, Y. Kizu, I. Takeda, F. Mizuno, Y. Hayashi, and I. Saito. 2004. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients. Immunology 111: 223-229. (Pubitemid 38177952)
64. + cells with characteristics of regulatory T cells. J. Immunol. 175: 4184-4188. (Pubitemid 41361950)
65. H17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71. (Pubitemid 351630328)
66. Veldhoen, M., K. Hirota, A. M. Westendorf, J. Buer, L. Dumoutier, J. C. Renauld, and B. Stockinger. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109. (Pubitemid 351630329)
67. H2 cells. Nat. Immunol. 10: 864-871.
68. Ramirez, J. M., N. C. Brembilla, O. Sorg, R. Chicheportiche, T. Matthes, J. M. Dayer, J. H. Saurat, E. Roosnek, and C. Chizzolini. 2010. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur. J. Immunol. 40: 2450-2459.
69. + T cells in an aryl hydrocarbon receptor (AhR)-dependent manner. PLoS ONE 6: e18741.
70. + regulatory T cells. Nat. Immunol. 11: 846-853.
71. Li, Y., S. Innocentin, D. R. Withers, N. A. Roberts, A. R. Gallagher, E. F. Grigorieva, C. Wilhelm, and M. Veldhoen. 2011. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147: 629-640.
72. Hammi, A. R., I. H. Al-Hashimi, M. E. Nunn, and M. Zipp. 2005. Assessment of SS - A and SS-B in parotid saliva of patients with Sjögren's syndrome. J. Oral Pathol. Med. 34: 198-203. (Pubitemid 40445152)
73. Schwarzmann, F., N. Prang, B. Reichelt, B. Rinkes, S. Haist, M. Marschall, and H. Wolf. 1994. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J. Gen. Virol. 75: 1999-2006. (Pubitemid 24243081)
74. Halse, A., J. B. Harley, U. Kroneld, and R. Jonsson. 1999. Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome. Clin. Exp. Immunol. 115: 203-207. (Pubitemid 29030386)
75. Tzioufas, A. G., I. Hantoumi, M. Polihronis, G. Xanthou, and H. M. Moutsopoulos. 1999. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs). J. Autoimmun. 13: 429-434. (Pubitemid 30014531)
76. Yannopoulos, D. I., S. Roncin, A. Lamour, Y. L. Pennec, H. M. Moutsopoulos, and P. Youinou. 1992. Conjunctival epithelial cells from patients with Sjögren's syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins. J. Clin. Immunol. 12: 259-265.